Evaluation of intralesional 5-fluorouracil versus intralesional interferon alpha in treatment of warts
Keywords:
5-Fluorouracil, Interferon Alpha, Warts, Verruca, Human PapillomavirusAbstract
Background: Warts are non-malignant growth of the skin and mucous membranes resulting from infection with human papillomavirus (HPV). It can significantly impact the quality of life for patients and elicit feeling of embarrassment. Aim and objectives: A comparative analysis of the efficacy of intralesional 5-FU and intralesional interferon alpha among distinct groups of patients diagnosed with warts. Patients and methods: This is a cohort of sixty individuals diagnosed with warts were selected from the period of early April 2022 to the end of April 2023. Results: There was a statistically significant difference (P-value=0.005) seen between the two groups, namely group A and group B, in relation to the final response. In group A (5-Fluorouracil)), complete clearance was achieved by 23 patients (76.7%), with 7 patients (23.3%) showing partial response. No instances of resistance were observed in this group. Conversely, in group B (Interferon alpha), only 11 patients (36.7%) attained complete clearance, while 16 patients (53.3%) exhibited partial response, and resistance was evident in 3 cases (10%). Conclusion: Intralesional 5-Fluorouracil (5-FU) is highly effective, cheaper, and easily available in treating warts. The combination of the both treatments may deliver a greater benefit to patients with resistant warts.
Downloads
References
Aksakal, A. A., Ozden, M. G., Atahan, C., & Onder, M. (2009). Successful treatment of verruca plantaris with a single sublesional injection of interferon‐α2a. Clinical and experimental dermatology, 34(1), 16-19.
Chen, L., Wu, Y., Sun, Y., Qiao, S., Xiao, B., Wang, J., ... & Gao, X. (2023). Combined therapy of local recombinant human interferon α1b injection and acupuncture on verruca vulgaris: a retrospective study. Archives of Dermatological Research, 315(8), 2365-2373.
Ghonemy, S., Ibrahim Ali, M., & Ebrahim, H. M. (2020). The efficacy of microneedling alone vs its combination with 5‐fluorouracil solution vs 5‐fluorouracil intralesional injection in the treatment of plantar warts. Dermatologic Therapy, 33(6), e14179.
Kamal, T., Ahmad, F., & Iftikhar, U. (2018). Efficacy and safety of intralesional 5-fluorouracil in treatment of warts. Journal of Pakistan Association of Dermatologists, 28(3), 337-339.
Kannambal, K., Kaviarasan, P. K., Prasad, P. V. S., Poorana, B., & Balajiganesh, J. (2019). Efficacy of intralesional 5-fluorouracil in recalcitrant warts a study at tertiary care centre. J Med Sci Clin Res, 7, 556-60.
Lynch, M. D., Cliffe, J., & Morris-Jones, R. (2014). Management of cutaneous viral warts. Bmj, 348.
Park, J. H., Kim, Y. K., & Choi, G. S. (2002). Combination Therapy with Intralesional Interferon ǯ-2b and Pulsed Dye Laser for the Treatment of Periungual Warts. Ann Dermatol, 14(2), 82-87.
Rafique, S., Hassan, T., Shahzad, M. K., Hanif, N., Rafique, S., & Rafique, S. (2023). Comparison of MMR Vaccine V/S 5-Fluorouracil in Treatment of Palmo-plantar Warts. Pakistan Journal of Medical & Health Sciences, 17(04), 76-76.
Vance, J. C., Bart, B. J., Hansen, R. C., Reichman, R. C., McEwen, C., Hatch, K. D., ... & Tanner, D. J. (1986). Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Archives of Dermatology, 122(3), 272-277.
Yazdanfar, A., Farshchian, M., Fereydoonnejad, M., & Farshchian, M. (2008). Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: a prospective placebo-controlled, double-blind randomized trial. Dermatologic surgery, 34(5), 656-659.
Published
How to Cite
Issue
Section
Copyright (c) 2024 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
